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Introduction: Synthol is a site enhancement oil used by bodybuilders to boost the cosmetic appearance of
muscles. Here, we describe the case of a patient with severe side effects following repeated intramuscular injections
of synthol in his right biceps muscle.
Case presentation: A 29-year-old Middle Eastern male bodybuilder, following intramuscular injections of synthol
five years ago, presented with painful pressure in his right upper arm. On presentation to our clinic, his muscle
appeared disfigured. Magnetic resonance imaging revealed scattered cystic fatty lesions in the muscle. The affected
part was surgically removed and histopathology showed inflammatory changes with fibrosis and a so-called Swiss
cheese pattern.
Conclusion: Synthol injections that are used for the short-term enhancement of muscle appearance by
bodybuilders bear the danger of long-term painful muscle fibrosis and disfigurement.Introduction
Site enhancement oils were first introduced in 1899 for
the purposes of breast augmentation and the filling of
wrinkles [1,2]. Synthol, one of the substances used for
this purpose, is composed of 85% oil (medium-chain tri-
glycerides), 7.5% lidocaine and 7.5% alcohol. Following
injection with synthol, the injected muscle undergoes
immediate enlargement. However, this method can also
result in muscle deformity [3].Case presentation
A 29-year-old Middle Eastern male bodybuilder with a
history of prior repeated synthol injections presented at
our clinic with ongoing pain and deformity in both
upper arms. At the age of 25, our patient had 3mL
synthol repeatedly injected by an unlicensed friend into
both biceps brachii muscles. Injections were adminis-
tered four times per week for a total period of four
weeks. The total number of injections was 16 injections
per biceps muscle. Our patient experienced pain and
pressure in the injected muscle directly after each injec-
tion. The pain was rated initially as four using a visual* Correspondence: ghandour@med.uni-marburg.de
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session was carried out by our patient after each injec-
tion. His perception of pain gradually increased to six
out of ten, and after two years our patient ceased train-
ing due to the severe pain (rated seven out of ten). Ini-
tially, our patient had been able to withstand the pain
but, after two years of drug administration, the pain was
increasing and not tolerable due to its constant and per-
sistent nature.
Upon physical examination, our patient was observed to
have rubbery firm hypertrophic and dysmorphic biceps in
both arms (Figure 1) with a free range of motion. He com-
plained of a constant painful pressure within his right
muscle more than his left one, and muscle deformity. He
had several tender points all over his biceps muscle. A
diagnosis was made through magnetic resonance imaging
(MRI), which revealed a swollen right biceps muscle and
cystic lesions scattered throughout the muscle tissue with
a hyperintense signal. MRI indicated these lesions to be oil
deposits between muscle fibers, termed oleomas (Figure 2).
It was concluded that his muscle underwent fibrotic
changes in its appearance. In addition, contrast enhance-
ment was inhomogeneous, indicating the presence of in-
flammation (Figure 3).
For ongoing pain and with no therapeutic alternatives,
an open surgical excision of the anterior third of hisntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Preoperative appearance of left biceps muscle. Right
hand not shown due to distinguishing features.
Figure 3 Gadolinium-enhanced transverse T1-spin echo
magnetic resonance image sequence with fat saturation of the
right arm. The inhomogeneous contrast enhancement of the
biceps muscle indicates the presence of inflammation.
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proach. Intraoperative findings showed no common
muscle tissue left but massive fibrotic tissue similar to
scar tissue. Postoperatively, our patient experienced a re-
lease of the subjective pain and intracompartmental
pressure.
The operative specimen, measuring 11.0cm× 5.0cm×
5.0cm, was sent to the Department of Neuropathology
for histological examination. The diagnosis was recon-
firmed as fibrosis. Sections of the unfixed material
revealed a white to yellowish lesion with intermingled
small fragments of muscle. Histology showed a predom-
inance of connective tissue with vacuoles (Figure 4A,B,
C) and small areas of striated muscle with myopathicFigure 2 Magnetic resonance image of swollen biceps muscle after in
spin echo sequence and (B) transverse T2-weighted turbo spin echo s
total muscle had a hyperintense signal in T1-weighted and T2-weighted im
lesions are scattered within the muscle with a hyperintense signal. These lechanges (Figure 4A,B,C; asterisks). Several necrotic
muscle fibers were observed. The connective tissue con-
tained inflammatory infiltrates that were in part diffusely
distributed, in part accumulated in foci (Figure 4A,B;
arrows). The infiltrates were dominated by CD68+
macrophages (Figure 4D) with numerous multinucleated
giant cells (Figure 4D; arrows) and lymphocytes
(Figure 4D; arrowhead). Immunohistochemistry identi-
fied the lymphocytes as CD4+ and CD8+ T-cells as well
as CD20+ B-cells (not shown).
Two weeks postoperatively, our patient was satisfied
with the outcome. He was advised to withhold vigorous
training for a period of 12 weeks. No complications were
reported. After six months, the patient requested the
same procedure to be done on his left biceps and surgery
was carried out later.tramuscular injection of synthol in (A) coronal T1-weighted turbo
equence. Due to the presence of fat in the injected suspension, the
ages compared with the surrounding healthy muscles. Several cystic
sions are oil deposits between the muscle bundles.
Figure 4 The overview shows the destroyed muscular architecture and replacement of the muscle by connective tissue. (A) Residual
muscle fibers (asterisks) show pronounced myopathic changes while the connective tissue contains vacuoles with inflammatory infiltrates
(arrows). Hematoxylin and eosin stain , ×10 magnification. (B) Higher magnification reveals inflammatory infiltrates in the connective tissue and
surrounding the vacuoles. Hematoxylin and eosin stain, ×40 magnification. (C) Elastica van Gieson stain shows remaining muscle fibers (asterisks)
with intermingled connective tissue and vacuoles, ×20 magnification. (D) Multinucleated giant cells (arrows) and mononuclear infiltrates
(arrowhead, cells negative for CD68) surround vacuoles, ×40 magnification.
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There are not many case reports in the literature that
document complications from the use of synthol in body-
builders. However, there are several reports of complica-
tions in patients after injections of paraffin, sesame- and
walnut oil [1,4-7]. They all share common histological
findings with an inflammatory foreign body reaction, fi-
brosis and extensive vacuolation [6]. The latter is also
known for producing a ‘Swiss cheese’ appearance [5,6],
while individual cysts are named according to the injected
material, for example, oleoma or paraffinoma [6,7].
Such enhancement oils do not increase muscular
strength or performance and are used solely for cosmetic
purposes [1]. In the presented case, our patient was
under social pressure to use synthol to improve his ap-
pearance. However, two years after the injections, the in-
creasing fibrosis and concomitant disfigurement of the
muscular appearance caused embarrassment due to his
negative body image. Other potential side effects that
have been reported include oil embolism, myocardial in-
farction, cerebral stroke, ulcers and infections [3,6].
Conclusions
Although the use of synthol by bodybuilders supplies
them with the desired short-term effects, the compoundprogressively destroys the injected muscle. Users are fre-
quently drawn to synthol as it does not share the side
effects of androgenic anabolic steroid hormones. How-
ever, our case study demonstrates that, despite these per-
ceived advantages, synthol can also have severe and
potential life-threatening consequences for its users.
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